EBS vs LULU · rev $742.9M vs P/E 17, rev $11.10B
Emergent Biosolutions Inc (EBS) versus Lululemon Athletica Inc. (LULU) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
Latest reported EBS revenue for 2025-12-31 was $742.9M. Net income was $52.6M. EBS currently screens at market cap $416.4M.
Latest reported LULU revenue for 2026-02-01 was $11.10B. Net income was $1.58B. Revenue was up 4.9% from 2025-02-02 to 2026-02-01. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
EBS currently screens at market cap $416.4M. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Not investment advice. Open the EBS and LULU stock pages for the full models.
Not investment advice.